Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.
2.

Spotlight on abciximab in patients with ischemic heart disease undergoing percutaneous coronary revascularization.

Ibbotson T, McGavin JK, Goa KL.

Am J Cardiovasc Drugs. 2003;3(5):381-6. Review.

PMID:
14728074
4.

An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.

Adgey AA.

Eur Heart J. 1998 Apr;19 Suppl D:D10-21. Review.

PMID:
9597518
5.

Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease.

Lincoff AM, Califf RM, Topol EJ.

J Am Coll Cardiol. 2000 Apr;35(5):1103-15. Review.

6.

Bleeding complications of glycoprotein IIb-IIIa receptor inhibitors.

Blankenship JC.

Am Heart J. 1999 Oct;138(4 Pt 2):287-96. Review.

PMID:
10502234
7.

A risk-benefit assessment of abciximab in angioplasty.

Kleiman NS.

Drug Saf. 1999 Jan;20(1):43-57. Review.

PMID:
9935276
8.

Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials.

Kandzari DE, Hasselblad V, Tcheng JE, Stone GW, Califf RM, Kastrati A, Neumann FJ, Brener SJ, Montalescot G, Kong DF, Harrington RA.

Am Heart J. 2004 Mar;147(3):457-62. Review.

PMID:
14999194
9.

Safety of glycoprotein IIb-IIIa inhibitors: A heart surgeon's perspective.

Dyke CM.

Am Heart J. 1999 Oct;138(4 Pt 2):307-16. Review.

PMID:
10502236
10.
12.
13.
14.
15.
16.

Efficacy of glycoprotein IIb/IIIa-receptor inhibitors during percutaneous coronary intervention.

Cheng JW.

Am J Health Syst Pharm. 2002 Nov 1;59(21 Suppl 7):S5-14. Review.

PMID:
12434710
17.

New antiplatelet agents: platelet GPIIb/IIIa antagonists.

Coller BS, Anderson K, Weisman HF.

Thromb Haemost. 1995 Jul;74(1):302-8. Review.

PMID:
8578476
18.

Acute profound thrombocytopenia following abciximab therapy.

Bishara AI, Hagmeyer KO.

Ann Pharmacother. 2000 Jul-Aug;34(7-8):924-30. Review.

PMID:
10928405
20.

Early use of glycoprotein IIb/IIIa-receptor inhibitors in non-ST-segment-elevation acute coronary syndromes.

Marsh JD.

Am J Health Syst Pharm. 2002 Nov 1;59(21 Suppl 7):S15-26. Review.

PMID:
12434711

Supplemental Content

Support Center